1. Home
  2. PRTA
  3. PRTA News

Latest Prothena Corporation plc (PRTA) News on May 20, 2025

Prothena Q1 Earnings Miss Estimates, Focus on Key Readouts in 2025
PRTA

Zacks

11 days ago

Prothena Q1 Earnings Miss Estimates, Focus on Key Readouts in 2025

PRTA

MT Newswires

11 days ago

RBC Trims Price Target on Prothena to $18 From $20, Keeps Sector Perform, Speculative Risk

Is Prothena Corporation plc (PRTA) the Low Risk High Reward Stock Set to Triple by 2030?
PRTA

Insider Monkey

11 days ago

Is Prothena Corporation plc (PRTA) the Low Risk High Reward Stock Set to Triple by 2030?

Prothena (PRTA) Reports Q1 Loss, Misses Revenue Estimates
PRTA

Zacks

11 days ago

Prothena (PRTA) Reports Q1 Loss, Misses Revenue Estimates

PRTA

Associated Press Finance

11 days ago

Prothena: Q1 Earnings Snapshot

Prothena Reports First Quarter 2025 Financial Results and Business Highlights
PRTA

Business Wire

11 days ago

Prothena Reports First Quarter 2025 Financial Results and Business Highlights

Insiders Re-Evaluate Their US$2.75m Stock Purchase As Prothena Falls To US$458m
PRTA

Simply Wall St.

16 days ago

Insiders Re-Evaluate Their US$2.75m Stock Purchase As Prothena Falls To US$458m

PRTA

MT Newswires

18 days ago

Prothena Corp Public Ltd Insider Bought Shares Worth $2,749,916, According to a Recent SEC Filing

Prothena to Report First Quarter 2025 Financial Results on May 8
PRTA

Business Wire

18 days ago

Prothena to Report First Quarter 2025 Financial Results on May 8

Prothena Full Year 2024 Earnings: Misses Expectations
PRTA

Simply Wall St.

3 months ago

Prothena Full Year 2024 Earnings: Misses Expectations

Prothena Q4 Earnings Miss Estimates, Pipeline Progress in Focus
PRTA

Zacks

3 months ago

Prothena Q4 Earnings Miss Estimates, Pipeline Progress in Focus

PRTA

MT Newswires

3 months ago

RBC Cuts Price Target on Prothena to $20 From $24, Keeps Sector Perform, Speculative Risk

Prothena Corp PLC (PRTA) Q4 2024 Earnings Call Highlights: Strong Financial Position Amidst ...
PRTA

GuruFocus.com

3 months ago

Prothena Corp PLC (PRTA) Q4 2024 Earnings Call Highlights: Strong Financial Position Amidst ...

Prothena (PRTA) Reports Q4 Loss, Misses Revenue Estimates
PRTA

Zacks

3 months ago

Prothena (PRTA) Reports Q4 Loss, Misses Revenue Estimates

PRTA

Associated Press Finance

3 months ago

Prothena: Q4 Earnings Snapshot

Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights
PRTA

Business Wire

3 months ago

Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights

Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
PRTA

Business Wire

3 months ago

Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Further weakness as Prothena (NASDAQ:PRTA) drops 16% this week, taking three-year losses to 61%
PRTA

Simply Wall St.

4 months ago

Further weakness as Prothena (NASDAQ:PRTA) drops 16% this week, taking three-year losses to 61%

BIIB Secures FDA Nod for Monthly Maintenance Dosing of Alzheimer's Drug
PRTA

Zacks

4 months ago

BIIB Secures FDA Nod for Monthly Maintenance Dosing of Alzheimer's Drug

Prothena Announces Board of Directors Update
PRTA

Business Wire

5 months ago

Prothena Announces Board of Directors Update

We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate
PRTA

Simply Wall St.

5 months ago

We're Not Very Worried About Prothena's (NASDAQ:PRTA) Cash Burn Rate

PRTA

MT Newswires

5 months ago

Chardan Initiates Coverage on Prothena With Buy Rating, $40 Price Target

Prothena Catapults, Flashing A Bullish Sign, On Promise In Parkinson's Disease
PRTA

Investor's Business Daily

5 months ago

Prothena Catapults, Flashing A Bullish Sign, On Promise In Parkinson's Disease

Prothena’s Parkinson’s study fails primary endpoint despite some success
PRTA

Clinical Trials Arena

5 months ago

Prothena’s Parkinson’s study fails primary endpoint despite some success

PRTA

MT Newswires

5 months ago

Prothena Says Study Evaluating Prasinezumab in Early-Stage Parkinson's Disease Missed Primary Endpoint

Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease
PRTA

Business Wire

5 months ago

Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease

Why Is Prothena (PRTA) Down 17.9% Since Last Earnings Report?
PRTA

Zacks

5 months ago

Why Is Prothena (PRTA) Down 17.9% Since Last Earnings Report?

Biogen Partner Eisai Gets Positive CHMP Nod for Leqembi in Europe
PRTA

Zacks

6 months ago

Biogen Partner Eisai Gets Positive CHMP Nod for Leqembi in Europe

Prothena Q3 Earnings Beat Estimates, Pipeline Progress in Focus
PRTA

Zacks

6 months ago

Prothena Q3 Earnings Beat Estimates, Pipeline Progress in Focus

Prothena (PRTA) Reports Q3 Loss, Misses Revenue Estimates
PRTA

Zacks

6 months ago

Prothena (PRTA) Reports Q3 Loss, Misses Revenue Estimates

PRTA

Associated Press Finance

6 months ago

Prothena: Q3 Earnings Snapshot

Prothena Reports Third Quarter 2024 Financial Results and Business Highlights
PRTA

Business Wire

6 months ago

Prothena Reports Third Quarter 2024 Financial Results and Business Highlights

Will These 5 Biotech Stocks Surpass Q3 Earnings Forecasts?
PRTA

Zacks

6 months ago

Will These 5 Biotech Stocks Surpass Q3 Earnings Forecasts?

Prothena to Report Third Quarter 2024 Financial Results on November 12
PRTA

Business Wire

6 months ago

Prothena to Report Third Quarter 2024 Financial Results on November 12

Prothena (PRTA) Upgraded to Buy: What Does It Mean for the Stock?
PRTA

Zacks

7 months ago

Prothena (PRTA) Upgraded to Buy: What Does It Mean for the Stock?

Strength Seen in Prothena (PRTA): Can Its 15.0% Jump Turn into More Strength?
PRTA

Zacks

7 months ago

Strength Seen in Prothena (PRTA): Can Its 15.0% Jump Turn into More Strength?

State Street Corp's Strategic Reduction in Prothena Corp PLC Holdings
PRTA

GuruFocus.com

7 months ago

State Street Corp's Strategic Reduction in Prothena Corp PLC Holdings

PRTA

MT Newswires

8 months ago

Update: Prothena's Shares Fall as Chief Medical Officer Departs

PRTA

MT Newswires

8 months ago

Prothena Names Chad Swanson as Chief Development Officer; Chief Medical Officer Departs

Eli Lilly Secures Approval for Alzheimer's Drug Kisunla in Japan
PRTA

Zacks

8 months ago

Eli Lilly Secures Approval for Alzheimer's Drug Kisunla in Japan

Prothena to Participate in Upcoming Healthcare Conferences
PRTA

Business Wire

9 months ago

Prothena to Participate in Upcoming Healthcare Conferences

What Makes Prothena (PRTA) a New Buy Stock
PRTA

Zacks

9 months ago

What Makes Prothena (PRTA) a New Buy Stock

Prothena Corporation plc (PTRA): Positioning Among Top Debt-Free Stocks
PRTA

Insider Monkey

9 months ago

Prothena Corporation plc (PTRA): Positioning Among Top Debt-Free Stocks

PRTA

MT Newswires

9 months ago

Oppenheimer Cuts Prothena Price Target to $62 From $66, Outperform Rating Maintained

Prothena (PRTA) Q2 Earnings Benefit From Collaboration Revenues
PRTA

Zacks

9 months ago

Prothena (PRTA) Q2 Earnings Benefit From Collaboration Revenues

Prothena (PRTA) Q2 Earnings and Revenues Beat Estimates
PRTA

Zacks

9 months ago

Prothena (PRTA) Q2 Earnings and Revenues Beat Estimates

PRTA

Associated Press Finance

9 months ago

Prothena: Q2 Earnings Snapshot

Prothena Reports Second Quarter 2024 Financial Results and Business Highlights
PRTA

Business Wire

9 months ago

Prothena Reports Second Quarter 2024 Financial Results and Business Highlights

Prothena to Report Second Quarter 2024 Financial Results on August 8
PRTA

Business Wire

10 months ago

Prothena to Report Second Quarter 2024 Financial Results on August 8

Merus N.V. (MRUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
PRTA

Zacks

10 months ago

Merus N.V. (MRUS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Prothena (PRTA) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
PRTA

Zacks

10 months ago

Prothena (PRTA) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Legend Biotech (LEGN) Surges 12.1%: Is This an Indication of Further Gains?
PRTA

Zacks

10 months ago

Legend Biotech (LEGN) Surges 12.1%: Is This an Indication of Further Gains?

Prothena (PRTA) Moves 9.3% Higher: Will This Strength Last?
PRTA

Zacks

a year ago

Prothena (PRTA) Moves 9.3% Higher: Will This Strength Last?

Here's Why We're Not Too Worried About Prothena's (NASDAQ:PRTA) Cash Burn Situation
PRTA

Simply Wall St.

a year ago

Here's Why We're Not Too Worried About Prothena's (NASDAQ:PRTA) Cash Burn Situation

The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)
PRTA

Zacks

a year ago

The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)

The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune
PRTA

Zacks

a year ago

The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune

Eli Lilly Seesaws On FDA Win, And Pushes Alzheimer's Stocks Prothena, Eisai Lower
PRTA

Investor's Business Daily

a year ago

Eli Lilly Seesaws On FDA Win, And Pushes Alzheimer's Stocks Prothena, Eisai Lower

Eli Lilly (LLY) Alzheimer's Drug Donanemab Gets FDA Panel Nod
PRTA

Zacks

a year ago

Eli Lilly (LLY) Alzheimer's Drug Donanemab Gets FDA Panel Nod

Biogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance
PRTA

Zacks

a year ago

Biogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance

Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?
PRTA

Zacks

a year ago

Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?

Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate
PRTA

Zacks

a year ago

Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate

Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate
PRTA

Zacks

a year ago

Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate

BMS stakes $80m on Prothena’s neurodegenerative candidate
PRTA

Pharmaceutical Technology

a year ago

BMS stakes $80m on Prothena’s neurodegenerative candidate

PRTA

MT Newswires

a year ago

Prothena to Receive $80 Million From Bristol-Myers Squibb For PRX019 Global License

Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration
PRTA

Business Wire

a year ago

Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration

News Flash: Analysts Just Made A Notable Upgrade To Their Prothena Corporation plc (NASDAQ:PRTA) Forecasts
PRTA

Simply Wall St.

a year ago

News Flash: Analysts Just Made A Notable Upgrade To Their Prothena Corporation plc (NASDAQ:PRTA) Forecasts

Analysts Have Lowered Expectations For Prothena Corporation plc (NASDAQ:PRTA) After Its Latest Results
PRTA

Simply Wall St.

a year ago

Analysts Have Lowered Expectations For Prothena Corporation plc (NASDAQ:PRTA) After Its Latest Results

Prothena (PRTA) Q1 Earnings Miss Estimates on Higher R&D Expenses
PRTA

Zacks

a year ago

Prothena (PRTA) Q1 Earnings Miss Estimates on Higher R&D Expenses

Prothena (PRTA) Reports Q1 Loss, Lags Revenue Estimates
PRTA

Zacks

a year ago

Prothena (PRTA) Reports Q1 Loss, Lags Revenue Estimates

PRTA

Associated Press Finance

a year ago

Prothena: Q1 Earnings Snapshot

Prothena Reports First Quarter 2024 Financial Results and Business Highlights
PRTA

Business Wire

a year ago

Prothena Reports First Quarter 2024 Financial Results and Business Highlights

We think Prothena Corporation plc's (NASDAQ:PRTA) CEO May Struggle To See Much Of A Pay Rise This Year
PRTA

Simply Wall St.

a year ago

We think Prothena Corporation plc's (NASDAQ:PRTA) CEO May Struggle To See Much Of A Pay Rise This Year

Prothena to Report First Quarter 2024 Financial Results on May 8
PRTA

Business Wire

a year ago

Prothena to Report First Quarter 2024 Financial Results on May 8

Earnings Preview: Prothena (PRTA) Q1 Earnings Expected to Decline
PRTA

Zacks

a year ago

Earnings Preview: Prothena (PRTA) Q1 Earnings Expected to Decline

Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
PRTA

Business Wire

a year ago

Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma

Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
PRTA

Investor's Business Daily

a year ago

Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback

CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
PRTA

Zacks

a year ago

CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug

Prothena to Participate in Upcoming Healthcare Conferences
PRTA

Business Wire

a year ago

Prothena to Participate in Upcoming Healthcare Conferences

Prothena Appoints David Ford to Newly Created Chief People Officer Position
PRTA

Business Wire

a year ago

Prothena Appoints David Ford to Newly Created Chief People Officer Position

Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate
PRTA

Business Wire

a year ago

Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate

Prothena Full Year 2023 Earnings: Beats Expectations
PRTA

Simply Wall St.

a year ago

Prothena Full Year 2023 Earnings: Beats Expectations

Prothena (PRTA) Q4 Earnings Miss Estimates on Higher R&D Expense
PRTA

Zacks

a year ago

Prothena (PRTA) Q4 Earnings Miss Estimates on Higher R&D Expense

Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript
PRTA

Insider Monkey

a year ago

Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript

PRTA

Associated Press Finance

a year ago

Prothena: Q4 Earnings Snapshot

PRTA

GuruFocus.com

a year ago

Prothena Corp PLC (PRTA) Reports 2023 Financial Results and Provides 2024 Outlook

Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
PRTA

Business Wire

a year ago

Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights

Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
PRTA

Business Wire

a year ago

Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024

Arvinas, Inc. (ARVN) Soars 10.0%: Is Further Upside Left in the Stock?
PRTA

Zacks

a year ago

Arvinas, Inc. (ARVN) Soars 10.0%: Is Further Upside Left in the Stock?

PRTA

Morningstar Research

a year ago

Analyst Report: Lazard, Inc.

Lazard (LAZ) Reports Q4 Earnings: What Key Metrics Have to Say
PRTA

Zacks

a year ago

Lazard (LAZ) Reports Q4 Earnings: What Key Metrics Have to Say

Here's What Key Metrics Tell Us About Conmed (CNMD) Q4 Earnings
PRTA

Zacks

a year ago

Here's What Key Metrics Tell Us About Conmed (CNMD) Q4 Earnings

Calix (CALX) Q4 Earnings Beat Estimates, Revenues Up Y/Y
PRTA

Zacks

a year ago

Calix (CALX) Q4 Earnings Beat Estimates, Revenues Up Y/Y

3 Reasons Growth Investors Will Love Silicon Motion (SIMO)
PRTA

Zacks

a year ago

3 Reasons Growth Investors Will Love Silicon Motion (SIMO)

$85M in Zulily Assets Set to Be Sold
PRTA

Sourcing Journal

a year ago

$85M in Zulily Assets Set to Be Sold

Princeton Bancorp (NASDAQ:BPRN) Has Affirmed Its Dividend Of $0.30
PRTA

Simply Wall St.

a year ago

Princeton Bancorp (NASDAQ:BPRN) Has Affirmed Its Dividend Of $0.30

EnerSys (ENS) Exceeds Market Returns: Some Facts to Consider
PRTA

Zacks

a year ago

EnerSys (ENS) Exceeds Market Returns: Some Facts to Consider

Gabelli Funds to Host Pump, Valve & Water Systems Symposium at The Yale Club, New York, NY
PRTA

GlobeNewswire

a year ago

Gabelli Funds to Host Pump, Valve & Water Systems Symposium at The Yale Club, New York, NY

New Forecasts: Here's What Analysts Think The Future Holds For The Bancorp, Inc. (NASDAQ:TBBK)
PRTA

Simply Wall St.

a year ago

New Forecasts: Here's What Analysts Think The Future Holds For The Bancorp, Inc. (NASDAQ:TBBK)

The Bancorp, Inc. (NASDAQ:TBBK) Q4 2023 Earnings Call Transcript
PRTA

Insider Monkey

a year ago

The Bancorp, Inc. (NASDAQ:TBBK) Q4 2023 Earnings Call Transcript

Amerant Bancorp Inc. (NASDAQ:AMTB) Q4 2023 Earnings Call Transcript
PRTA

Insider Monkey

a year ago

Amerant Bancorp Inc. (NASDAQ:AMTB) Q4 2023 Earnings Call Transcript

Share on Social Networks: